CoChat

5,6,7,8-Tetrahydro-1,6-naphthyridine Derivatives as Potent HIV-1-Integrase-Allosteric-Site Inhibitors

The DOI matches its Crossref record; 37 of the 39 references it cites were found in a registry or an index.

Abstract

A series of 5,6,7,8-tetrahydro-1,6-naphthyridine derivatives targeting the allosteric lens-epithelium-derived-growth-factor-p75 (LEDGF/p75)-binding site on HIV-1 integrase, an attractive target for antiviral chemotherapy, was prepared and screened for activity against HIV-1 infection in cell culture. Small molecules that bind within the LEDGF/p75-binding site promote aberrant multimerization of the integrase enzyme and are of significant interest as HIV-1-replication inhibitors. Structure-activity-relationship studies and rat pharmacokinetic studies of lead compounds are presented.

Overview

Integrity signals

Registry

Crossref · 10.1021/acs.jmedchem.8b01473

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 37 references

Research works printed but not linked: 1

  1. Mitchell, M.; Balakrishnan, M.; Brizgys, G.; Cai, R.; Lansdon, E.; Mulato, A.; Osier, M.; Wang, J.; Yu, H.; Sakowicz, R. Novel non-catalytic site integrase inhibitor with improved resistance profile. Presented at the 24th Conference on Retroviruses and Opportunistic Infections (CROI), Seattle, WA, Feb 13–16, 2017; Poster 434.

Cited by

See all 42

Metadata

Authors
Peese, K. M., Allard, C. W., Connolly, T., Johnson, B. L., Li, C., Patel, M., Sorensen, M. E., Walker, M. A., Meanwell, N. A., McAuliffe, B., Minassian, B., Krystal, M., Parker, D. D., Lewis, H. A., Kish, K., Zhang, P., Nolte, R. T., Simmermacher, J., Jenkins, S., Cianci, C., & Naidu, B. N.
Affiliations
  • Bristol-Myers Squibb (United States) (US)
  • GlaxoSmithKline (United States) (US)
Corresponding author
Peese, Kevin M.
Venue
Journal of Medicinal Chemistry
Published
2019-01-04
Volume
62
Issue
3
Pages
1348-1361
ISSN
  • 0022-2623 (ISSN-L)
  • 1520-4804
OpenAlex
W2911092752
Cited by
39
References
39
Citations by year
2026: 3 · 2025: 2 · 2024: 2 · 2023: 3 · 2022: 9 · 2021: 8 · 2020: 7 · 2019: 5
FWCI
6.13
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Medicinal Chemistry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
  • Physical Sciences › Chemistry › Organic Chemistry › Heterocyclic Compound Synthesis and Bioactivity
Keywords
HIV-1 integrase inhibitors, allosteric inhibitors, integrase multimerization, antiviral agents, structure-activity relationship, pharmacokinetics, HIV-1 replication
MeSH terms
Allosteric Site, Humans, Naphthyridines, Virus Replication, HIV-1, HIV Infections, Crystallography, X-Ray, HIV Integrase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: 5,6,7,8-Tetrahydro-1,6-naphthyridine Derivatives as Potent HIV-1-Integrase-Allosteric-Site Inhibitors. https://app.cochat.ai/papers/10.1021/acs.jmedchem.8b01473
The paper
Peese, K. M., Allard, C. W., Connolly, T., Johnson, B. L., Li, C., Patel, M., Sorensen, M. E., Walker, M. A., Meanwell, N. A., McAuliffe, B., Minassian, B., Krystal, M., Parker, D. D., Lewis, H. A., Kish, K., Zhang, P., Nolte, R. T., Simmermacher, J., Jenkins, S., . . . Naidu, B. N. (2019). 5,6,7,8-Tetrahydro-1,6-naphthyridine Derivatives as Potent HIV-1-Integrase-Allosteric-Site Inhibitors. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.8b01473

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.